Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

5.8K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
5.8K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

3.3K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.3K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

4.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
4.6K
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

2.2K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.2K
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers01:17

Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

1.9K
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
1.9K
Sympathetic Signaling01:31

Sympathetic Signaling

3.5K
Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: Results from a prospective observational study in Germany.

Frontiers in public health·2022
Same author

Influence of dietary supplementation of short-chain fatty acid sodium propionate in people living with HIV (PLHIV).

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Sexual behaviour, STI knowledge and Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) prevalence in an asymptomatic cohort in Ruhr-area, Germany: PreYoungGo study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Age specific evaluation of sexual behavior, STI knowledge and infection among asymptomatic adolescents and young adults.

Journal of infection and public health·2020
Same author

Pregnancy outcomes after maternal varenicline use; analysis of surveillance data collected by the European Network of Teratology Information Services.

Reproductive toxicology (Elmsford, N.Y.)·2016
Same author

PP085. Angiotensin II type 1 receptor antibodies increase angiotensin II sensitivity in pregnant rats.

Pregnancy hypertension·2015

Related Experiment Video

Updated: Apr 13, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

18.6K

The beta 1-adrenoceptor as antigen: functional aspects

G Wallukat1, A Kayser, A Wollenberger

  • 1Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany.

European Heart Journal
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Autoantibodies targeting the beta 1-adrenoceptor in myocarditis and dilated cardiomyopathy patients cause positive chronotropic effects in heart cells. These effects are blocked by specific receptor blockade or peptides.

More Related Videos

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
10:13

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Published on: June 9, 2017

17.5K
Detection of G Protein-coupled Receptor Expression in Mouse Vagal Afferent Neurons using Multiplex In Situ Hybridization
08:16

Detection of G Protein-coupled Receptor Expression in Mouse Vagal Afferent Neurons using Multiplex In Situ Hybridization

Published on: September 20, 2021

4.8K

Related Experiment Videos

Last Updated: Apr 13, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

18.6K
Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
10:13

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Published on: June 9, 2017

17.5K
Detection of G Protein-coupled Receptor Expression in Mouse Vagal Afferent Neurons using Multiplex In Situ Hybridization
08:16

Detection of G Protein-coupled Receptor Expression in Mouse Vagal Afferent Neurons using Multiplex In Situ Hybridization

Published on: September 20, 2021

4.8K

Area of Science:

  • Cardiology
  • Immunology
  • Molecular Biology

Background:

  • Myocarditis and idiopathic dilated cardiomyopathy are linked to autoantibodies.
  • These autoantibodies target the beta 1-adrenoceptor, a key regulator of heart rate and contractility.

Purpose of the Study:

  • To investigate the nature and functional effects of autoantibodies against the beta 1-adrenoceptor in patients with myocarditis and idiopathic dilated cardiomyopathy.
  • To identify the specific epitopes recognized by these autoantibodies and the signaling pathways involved.

Main Methods:

  • Sera from patients were tested for autoantibodies against the beta 1-adrenoceptor.
  • The binding sites (epitopes) on the receptor were mapped using peptides.
  • Functional effects on neonatal rat heart myocytes were assessed, including chronotropic effects.
  • The role of beta 1-adrenoceptor blockade and specific peptides in inhibiting these effects was evaluated.
  • The intracellular signaling cascade (beta-adrenoceptor-adenylate cyclase-protein kinase A) was investigated.

Main Results:

  • Agonistic autoantibodies binding to the beta 1-adrenoceptor were detected in patient sera.
  • These antibodies recognized epitopes on the first or second extracellular loops of the receptor.
  • The autoantibodies induced a positive chronotropic effect in cultured heart myocytes.
  • This effect was abrogated by beta 1-adrenoceptor blockade and by peptides corresponding to the receptor's extracellular loops.
  • The primary mechanism involved the beta-adrenoceptor-adenylate cyclase-protein kinase A pathway.

Conclusions:

  • Autoantibodies against the beta 1-adrenoceptor contribute to the pathophysiology of myocarditis and idiopathic dilated cardiomyopathy.
  • These autoantibodies act as agonists, mimicking the effects of the natural ligand and activating the heart.
  • Targeting these autoantibodies or their binding sites may offer therapeutic potential for these conditions.